SH
Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY · OTC
$7.24 +0.00% (+$0.00)
1M -2.03%
Market Cap ¥36.0B
P/E Ratio 7.55x
Div. Yield 1.17%
ROE 6.20%
Bulios Fair Price
$9.72
34.3% upside
Current Price
$7.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHPMY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 7.55x
EV/EBITDA 6.42x
PEG 0.24x
Growth
55 /100
Stable EPS growth 1.47%
Rev. growth 6.92%
Book val. growth 4.21%
Profitability
15 /100
Weak Gross margin 10.81%
Net margin 1.65%
FCF margin 2.63%
Quality
33 /100
Poor ROIC 3.64%
ROE 6.20%
Asset turnover 1.20x
Debt
57 /100
Moderate Debt/Equity 0.84x
Current ratio 1.34x
Net debt/EBITDA 2.98x
Stability
63 /100
Moderate Beta 0.16x
Rev. volatility 4.71%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHPMY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Qiuhua Yang
Employees
49,608
Headquarters
Shanghai
Upcoming events
17 SEP
Ex-Dividend
Ex-dividend date
12 NOV
Dividend Payment
Payment date